Meeting Coverage:

American Academy of Ophthalmology

AAO: 2019

Preventing Vision Loss in Keratoconus

Show Description +

Michael W. Belin, MD, discusses how ophthalmologists should be monitoring for keratoconus progression in light of the new modalities available for the treatment of the disease. He also speaks about his classification system (the ABCD system) and progression display, both of which are designed to allow ophthalmologists to identify true progressive disease before a loss of vision occurs.

Posted: 10/02/2019

Keywords:

Keratoconus

Up Next

Efficacy of Presbyond for the Correction of Presbyopia

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO


Autonomous AI in Ophthalmology

Michael D. Abramoff, MD, PhD

CXL for Infectious Keratitis

Farhad Hafezi, MD, PhD, FARVO

MIGS and Medications

Alex Huang, MD

Controlling Wound Healing Following PRK

Farhad Hafezi, MD, PhD, FARVO

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS

PANORAMA Study Data

Rishi P. Singh, MD

Gene Therapy for Wet AMD

Szilard Kiss, MD

ABC to Block VEGF-A Isoforms

Charles C. Wykoff, MD, PhD

Surgery for Viral Retinitis

J. Fernando Arevalo, MD, PhD, FACS

Iridocorneal Endothelial Syndrome

Lauren S. Blieden, MD

Advanced Diagnostics in Refractive Surgery: Epithelial Mapping and Phakic IOL Sizing

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Preventing Vision Loss in Keratoconus

Michael W. Belin, MD, discusses how ophthalmologists should be monitoring for keratoconus progression in light of the new modalities available for the treatment of the disease. He also speaks about his classification system (the ABCD system) and progression display, both of which are designed to allow ophthalmologists to identify true progressive disease before a loss of vision occurs.

Posted: 10/02/2019

Keywords:

Keratoconus

Please log in to leave a comment.

Comments

jeff eger

4 years ago

Infection with cross linking?

jeff eger

4 years ago

Listened do I get COPE approval drjeffeger@cox.net

More From AAO: 2019 Coverage

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS